Name | SARS-CoV-2-IN-22 |
---|
Description | SARS-CoV-2-IN-22 is a SARS-CoV-2 pseudovirus entry inhibitor with an IC50 value of 16.96 µM[1]. |
---|---|
Related Catalog | |
Target |
IC50: 16.96 µM (SARS-CoV-2)[1] |
In Vitro | SARS-CoV-2-IN-22 (Compound 9a) effectively blocks the binding of SARS-CoV-2 to the host ACE2 receptor through dual recognition of SARS-CoV-2 spike receptor-binding domain (RBD) and human ACE2. SARS-CoV-2-IN-2 displays no cytotoxicity to normal cells (LO2)[1]. |
References |
Molecular Formula | C27H24N2O3S |
---|---|
Molecular Weight | 456.56 |